ESTRO 2025 - Abstract Book

S1911

Clinical - Urology

ESTRO 2025

Conclusion: MRgSBRT with IPL boosting demonstrates a favorable toxicity profile and promising early clinical outcomes in patients with localized PC. Further research, especially with a longer follow-up, is warranted to validate these preliminary results.

Keywords: MR-guidance, SBRT, prostate cancer

References: [1] Kishan AU, Ma TM, Lamb JM, Casado M, Wilhalme H, Low DA, et al. Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial. JAMA Oncol. 2023;9:365-73. [2] Nigogosyan Z, Ippolito JE, Collins SP, Wang EC. Prostate MRI in Stereotactic Body Radiation Treatment Planning and Delivery for Localized Prostate Cancer. Radiographics. 2022;42:1251-64. [3] Poon DMC, Yuan J, Yang B, Kerkmeijer LGW, Kishan AU, Murthy V, et al. Magnetic resonance imaging – guided focal boost to intraprostatic lesions using external beam radiotherapy for localized prostate cancer: A systematic review and meta-analysis. Eur Urol Oncol. 2023;6:116-27.